Gates’ Globalist Vaccine Agenda: A Win-Win for Pharma and

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
215
Gates’ Globalist Vaccine Agenda: A Win-Win for Pharma and Mandatory Vaccination

https://childrenshealthdefense.org/news/gover...ccination/

Vaccines, for Bill Gates, are a strategic philanthropy that feed his many vaccine-related businesses (including Microsoft’s ambition to control a global vaccination ID enterprise) and give him dictatorial control of global health policy.

Gates’ obsession with vaccines seems to be fueled by a conviction to save the world with technology.

Promising his share of $450 million of $1.2 billion to eradicate Polio, Gates took control of India’s National Technical Advisory Group on Immunization (NTAGI) which mandated up to 50 doses (Table 1) of polio vaccines through overlapping immunization programs to children before the age of five. Indian doctors blame the Gates campaign for a devastating non-polio acute flaccid paralysis (NPAFP) epidemic that paralyzed 490,000 children beyond expected rates between 2000 and 2017. In 2017, the Indian government dialed back Gates’ vaccine regimen and asked Gates and his vaccine policies to leave India. NPAFP rates dropped precipitously.

In 2017, the World Health Organization (WHO) reluctantly admitted that the global explosion in polio is predominantly vaccine strain. The most frightening epidemics in Congo, Afghanistan, and the Philippines, are all linked to vaccines. In fact, by 2018, 70% of global polio cases were vaccine strain.

In 2014, the Gates Foundation funded tests of experimental HPV vaccines, developed by Glaxo Smith Kline (GSK) and Merck, on 23,000 young girls in remote Indian provinces. Approximately 1,200 suffered severe side effects, including autoimmune and fertility disorders. Seven died. Indian government investigations charged that Gates-funded researchers committed pervasive ethical violations: pressuring vulnerable village girls into the trial, bullying parents, forging consent forms, and refusing medical care to the injured girls. The case is now in the country’s Supreme Court.

In 2010, the Gates Foundation funded a phase 3 trial of GSK’s experimental malaria vaccine, killing 151 African infants and causing serious adverse effects including paralysis, seizure, and febrile convulsions to 1,048 of the 5,949 children.

During Gates’ 2002 MenAfriVac campaign in Sub-Saharan Africa, Gates’ operatives forcibly vaccinated thousands of African children against meningitis. Approximately 50 of the 500 children vaccinated developed paralysis. South African newspapers complained, “We are guinea pigs for the drug makers.” Nelson Mandela’s former Senior Economist, Professor Patrick Bond, describes Gates’ philanthropic practices as “ruthless and immoral.”

In 2010, Gates committed $10 billion to the WHO saying, “We must make this the decade of vaccines.” A month later, Gates said in a Ted Talk that new vaccines “could reduce population”. In 2014, Kenya’s Catholic Doctors Association accused the WHO of chemically sterilizing millions of unwilling Kenyan women with a “tetanus” vaccine campaign. Independent labs found a sterility formula in every vaccine tested. After denying the charges, WHO finally admitted it had been developing the sterility vaccines for over a decade. Similar accusations came from Tanzania, Nicaragua, Mexico, and the Philippines.

A 2017 study (Morgenson et. al. 2017) showed that WHO’s popular DTP vaccine is killing more African children than the diseases it prevents. DTP-vaccinated girls suffered 10x the death rate of children who had not yet received the vaccine. WHO has refused to recall the lethal vaccine which it forces upon tens of millions of African children annually.

Global public health advocates around the world accuse Gates of steering WHO’s agenda away from the projects that are proven to curb infectious diseases: clean water, hygiene, nutrition, and economic development. The Gates Foundation only spends about $650 million of its $5 billion dollar budget on these areas. They say he has diverted agency resources to serve his personal philosophy that good health only comes in a syringe.

In addition to using his philanthropy to control WHO, UNICEF, GAVI, and PATH, Gates funds a private pharmaceutical company that manufactures vaccines, and additionally is donating $50 million to 12 pharmaceutical companies to speed up development of a coronavirus vaccine. In his recent media appearances, Gates appears confident that the Covid-19 crisis will now give him the opportunity to force his dictatorial vaccine programs on American children.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

VISTAR Oakland Workers Join Teamsters for Unity

Updated Category News Views 9

Warehouse Workers Break Free from the Shackles Ever had that feeling, where enough is enough? That's where 37 warehouse workers at VISTAR find themselves, shaking off the dust and signing up with Teamsters Local 853. This ain't just a fleeting wind of change; it's the whole damn storm. Turning Points and Union Victories Think about it. This move by the VISTAR warehouse...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 14

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 11

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Ryan Stills: Vegan Powerlifter Defies Odds, Wins Sixth World Title

Updated Category News Views 7

Ryan Stills: A Comeback Story for the Ages Ryan Stills isn't just lifting weights; he's lifting the entire perception of what's possible after a heavy surgical setback. We're talking about a guy who stared down a hemi-shoulder replacement—a career ender for many—and came out the other side with a whole new set of gold medals. Two years ago, some might have written him...

Continue Reading
Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Updated Category News Views 6

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 15

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 10

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Community Heritage Financial Declares Q3 2026 Dividend

Updated Category News Views 5

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Continue Reading
Kenneth Smith Takes Helm for Trends Int’l Expansion

Updated Category News Views 11

Tired of the Same Old Leadership Shuffle? Here Comes Kenneth Smith Look, I’ve seen my share of execs come and go, usually dragging the same old briefcase of stale ideas. But Kenneth Smith stepping up as CEO of Trends International? Now that’s got some real teeth to it. Come May 2026, he’s the guy at the helm, and he's got one hell of a to-do list. Smith's Roadmap: A...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 7

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading

Top 5 Most Recently Viewed Articles

Reklaim Welcomes Mark Thompson to Enhance Privacy Solutions

Updated Category News Views 155

Reklaim Expands Leadership Team with Mark Thompson Reklaim Ltd. (TSXV: MYID) has made an exciting move by hiring Mark Thompson, a former President at Norton, as its new Vice President of Product. This strategic addition aims to spearhead the growth and innovation of Reklaim Protect, a platform designed to fortify consumer privacy. Understanding Reklaim Protect Reklaim...

Continue Reading
HIMS Faces Class Action: Investors Eye Leadership

Updated Category News Views 8

Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...

Continue Reading
Discover the New Summer Cannabis Offerings from Tilray Brands

Updated Category News Views 255

Introducing Tilray Brands' Vibrant Summer Cannabis Collection As summer approaches, excitement fills the air as Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a leading name in the cannabis and consumer goods sector, unveils its newest cannabis products designed to elevate your summer experiences. With a commitment to quality and innovation, Tilray's collection showcases...

Continue Reading
Bristol Myers Squibb Highlights 10-Year Survival Data in Melanoma

Updated Category News Views 104

Significant 10-Year Follow-Up Results for Melanoma Treatments Bristol Myers Squibb has unveiled promising data from the CheckMate-067 study, a crucial Phase 3 clinical trial. These findings, resulting from a decade's worth of follow-up, highlight the lasting survival benefits of combining Opdivo (nivolumab) with Yervoy (ipilimumab) as a first-line treatment for advanced...

Continue Reading
Discover the Innovative ecozy Ice Maker: Your Ice Solution

Updated Category News Views 153

Introducing the ecozy Ice Maker: Your New Home Ice Production Solution The ecozy ice maker has arrived to change how we create ice at home. This compact countertop appliance combines convenience with innovative features, making it a must-have for any household that appreciates efficiency and style. Enjoy Flexibility with a Dual Water Supply System What distinguishes this...

Continue Reading